89 related articles for article (PubMed ID: 23597641)
1. Switching prostaglandin analogues and 24-hour IOP fluctuations.
Gil-Carrasco F; Turati-Acosta M; Albis-Donado O; Bello-López-Portillo H; Sánchez-Noguera C; Soto-Ortiz K
Arch Soc Esp Oftalmol; 2013 Apr; 88(4):130-3. PubMed ID: 23597641
[TBL] [Abstract][Full Text] [Related]
2. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma.
Nakamoto K; Yasuda N
J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997
[TBL] [Abstract][Full Text] [Related]
3. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
4. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
7. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
[TBL] [Abstract][Full Text] [Related]
10. The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost.
Li Yim JF; Montgomery DM
Curr Med Res Opin; 2011 Aug; 27(8):1499-502. PubMed ID: 21651425
[TBL] [Abstract][Full Text] [Related]
11. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
Holló G; Bozkurt B; Irkec M
Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
[TBL] [Abstract][Full Text] [Related]
12. Brinzolamide.
Iester M
Expert Opin Pharmacother; 2008 Mar; 9(4):653-62. PubMed ID: 18312166
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
[TBL] [Abstract][Full Text] [Related]
14. Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
Liu JH; Realini T; Weinreb RN
Ophthalmology; 2011 Oct; 118(10):1995-2000. PubMed ID: 21676464
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.
Martinez-de-la-Casa JM; Castillo A; Garcia-Feijoo J; Mendez-Hernandez C; Fernandez-Vidal A; Garcia-Sanchez J
Curr Med Res Opin; 2004 Sep; 20(9):1333-9. PubMed ID: 15383180
[TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides.
Martínez A; Sánchez M
Curr Med Res Opin; 2007 Mar; 23(3):595-9. PubMed ID: 17355740
[TBL] [Abstract][Full Text] [Related]
17. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
18. Brinzolamide--a new topical carbonic anhydrase inhibitor for glaucoma.
Med Lett Drugs Ther; 1998 Sep; 40(1036):95-6. PubMed ID: 9774966
[No Abstract] [Full Text] [Related]
19. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
20. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
Nakakura S; Nomura Y; Ataka S; Shiraki K
J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
